Clinical Trial Update: Trial of Parkinson's And Zoledronic Acid [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating zoledronic acid in patients with Parkinson's disease and osteoporosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies
• Multiple System Atrophy
• Osteoporosis
• Parkinson Disease
• Progressive Supranuclear Palsy
• Vascular Parkinsonism

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: California Pacific Medical Center Research Institute | Conditions: Parkinson Disease, Osteoporosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING